Gastric Variceal Bleeding: The Efficacy and Safety of N-Butyl-2-Cyanoacrylate Glue Injection

Aims: To assess N-2-butyl cyanoacrylate injection’s effectiveness and safety in the treatment of gastric varix hemorrhage. Methods: Endoscopic with N-Butyl-2-cyanoacrylate injection was performed on 32 patients (21 males 11 females) variceal bleeding. The socioeconomic status patients, initial hemostasis, rebleeding rate, complications, mortality rate were all reviewed retrospectively. Patients liver cirrhosis who presented hematemesis or melena whose endoscopy revealed bleeding included. Therefore, hemodynamic instability excluded. Results: A total underwent Histoacryl® glue to treat varices. mean age 56.09 ± 9.29 (mean SD) years old. Viral hepatitis is leading cause chronic disease, both B C accounted for cases (34.4%). IGV1 most commonly seen, according Sarin classification, 15 (46.8%), followed by GOV1 10 (31.3%) GOV2 7 (21.9%). With (46.9%), majority had a Child-Pugh (CTP) score. 12 (37.5%) (34.4%), respectively, melena, reported. In hemostasis achieved, there no documented complication rate. Conclusion: Given higher great results, our study’s findings indicate that N-butyl-2-cyanoacrylate under endoscopic guidance safe effective management GV After injection, achieved patients.